Early buyers will receive 10% customization on reports.
The report segments this market based on products, type of hearing loss, end-users, and regions. Among the various products, the hearing aids segment is expected to account for the largest share of the market while hearing implants segment is projected to grow at the highest CAGR from 2015 to 2020. The high growth in this segment can be attributed to the increasing technological advancements and regulatory approvals.
On the basis of type of hearing loss, the hearing aids market is segmented into sensorineural and conductive. The sensorineural segment is expected to account for the largest share of the global market in 2015. High prevalence of hearing loss and rising aging population are the factors propelling the growth of this market.
End-users, included in this market are adult and pediatric. The adult segment is expected to account for the largest share of the global market in 2015. High incidence of hearing loss with increasing ageing is driving the growth of this market.
Based on regions, the global hearing aids market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Europe is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as high prevalence of hearing loss, increase in aging population, and increasing number of research activities to develop new and advanced hearing aid products in Europe.
Key players in this market include Cochlear Limited (Australia), GN Store Nord A/S (Denmark), MED-EL (Austria), SeboTek Hearing Systems, LLC (U.S.), Sivantos Pte. Ltd. (Singapore), Sonova (Switzerland), Starkey Hearing Technologies, Inc. (U.S.), Widex (Denmark), William Demant Holding A/S (Denmark), and Zounds Hearing, Inc. (U.S.).
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain points around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 Micro Quadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
